|
[89Zr]DFO-YS5 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: 89Zirconium-89 DFO conjugated to the YS5 monoclonal antibody
Pipeline
Phase 1: 1
Top Sponsors
- Robert Flavell, MD, PhD1
Indications
- Nerve Sheath Tumor, Nos1
- Solid Tumor Neoplasms1
- Nerve Sheath Tumors1
- Nerve Sheath Tumor1
- Bladder Neoplasm1
San Francisco, California1 trial
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
University of California, San Francisco
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.